Web Innovators, Pharma, Insurance and Government Converge to Speak at Health 2.0 Europe

6-7 April 2010, Paris, France.
Health 2.0 Europe, a conference dedicated to how Web 2.0 and social media are transforming healthcare systems in Europe, has finalized its agenda and speaker list. Encompassing all aspects of the healthcare chain, the interactive program will address healthcare on both country- and European-wide levels, with local experts from converging industries.

"Health 2.0 Europe will show that Europe is producing creative e-health solutions to address the diversity of its 23 languages and 27 markets," said Denise Silber, president of Basil Strategies, organizer of the Paris event with Health 2.0's founders, Matthew Holt and Indu Subaiya.

Three keynote speakers will present government's perspective on Health 2.0 and national IT strategies on health and wellness:

  • Morten Elbæk Petersen, sundhed.dk (Denmark)
  • Etienne Caniard, National Authority for Health (France)
  • Pieter Vos, Council for Public Health and Health Care (Netherlands)

Panel topics include:

  • Search and content
  • Patients online communities
  • Physician online communities
  • Health 2.0 tools
  • Pharma and Health 2.0
  • Hospitals, payers and Health 2.0
  • Looking ahead for Health 2.0

Panel participants include influential members of Europe's eHealth community from 12 countries (Belgium, France, Germany, Hungary, Ireland, Italy, Netherlands, Spain, Sweden, Switzerland, and the UK). Panel structures will differ from traditional conference formats to encourage interactive participation. Speakers will perform a demo of their organization's 2.0 tool and discuss the impact of each tool nationally and in Europe. The agenda also features Launch, Health 2.0 Europe's segment for showcasing European eHealth start-ups.

For further information and registration, please visit:
http://www.health2con.com/paris2010

About Health 2.0 Europe
Health 2.0 Europe is the premier conference dedicated to how Web 2.0 and social media are transforming healthcare systems in Europe. The conference brings together professionals in the converging industries of healthcare, the internet, mobile applications and social media. Health 2.0 Europe is organized by pioneering experts from Europe and the U.S. with decades of combined experience in health- and Web- related business and consulting, Matthew Holt and Indu Subaiya, founders of Health 2.0 in San Francisco, and Denise Silber, president of Basil Strategies in Paris. Please visit www.health2con.com/paris2010 for more information.

Most Popular Now

Pfizer receives positive FDA Advisory Committee vo…

Pfizer Inc. (NYSE: PFE) announced that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that avail...

Engineered bacteria find tumors, then alert the au…

Combining discoveries in cancer immunology with sophisticated genetic engineering, Columbia University researchers have created a sort of "bacterial suicide squad" that ...

First nasal monoclonal antibody treatment for COVI…

A pilot trial by investigators from Brigham and Women's Hospital, a founding member of the Mass General Brigham healthcare system, tested the nasal administration of the ...

US FDA Advisory Committee votes to support effecti…

GSK plc (LSE/NYSE: GSK) announced that the US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted that the avail...

"Semantic similarity" leads to novel dru…

The words that researchers use to describe their results can be harnessed to discover potential new treatments for Parkinson's disease, according to a new study published...

Tumour cells' response to chemotherapy is driven b…

Cancer cells have an innate randomness in their ability to respond to chemotherapy, which is another tool in their arsenal of resisting treatment, new research led by the...

Pfizer's ZAVZPRET™ (zavegepant) migraine nasal spr…

Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) has approved ZAVZPRET™ (zavegepant), the first and only calcitonin gene-related peptid...

Pfizer invests $43 billion to battle cancer

Pfizer Inc. (NYSE: PFE) and Seagen Inc. (Nasdaq: SGEN) today announced that they have entered into a definitive merger agreement under which Pfizer will acquire Seagen, a...

Gene and cell therapies to combat pancreatic cance…

Pancreatic cancer is an incurable form of cancer, and gene therapies are currently in clinical testing to treat this deadly disease. A comprehensive review of the gene an...

Scientists reveal a potential new approach to trea…

Scientists at the National Institutes of Health and Massachusetts General Hospital in Boston have uncovered a potential new approach against liver cancer that could lead ...

Normalizing tumor blood vessels may improve immuno…

A type of immune therapy called chimeric antigen receptor (CAR)-T cell therapy has revolutionized the treatment of multiple types of blood cancers but has shown limited e...

Digital twin opens way to effective treatment of i…

Inflammatory diseases like rheumatoid arthritis have complex disease mechanisms that can differ from patient to patient with the same diagnosis. This means that currently...